Prognostic factors in renal cell carcinoma: A single‑center study

Ali,Rawa M.; Muhealdeen,Dana N.; Fakhralddin,Saman S.; Bapir,Rawa; Tahir,Soran H.; Rashid,Rezheen J.; Omer,Choman Sabah; Abdullah,Hiwa O.; Abdalla,Berun A.; Mohammed,Shvan H.; Kakamad,Fahmi H.; Abdullah,Fakher; Karim,Muhammad; Rahim,Hawbash M.

doi:10.3892/mco.2023.2662

Prognostic factors in renal cell carcinoma: A single‑center study

Authors:
- Rawa M. Ali
- Dana N. Muhealdeen
- Saman S. Fakhralddin
- Rawa Bapir
- Soran H. Tahir
- Rezheen J. Rashid
- Choman Sabah Omer
- Hiwa O. Abdullah
- Berun A. Abdalla
- Shvan H. Mohammed
- Fahmi H. Kakamad
- Fakher Abdullah
- Muhammad Karim
- Hawbash M. Rahim
View Affiliations

Affiliations: Scientific Affairs Department, Smart Health Tower, Sulaymaniyah, Kurdistan 46001, Iraq, Department of Oncology, Hiwa Hospital, Sulaymaniyah, Kurdistan 46001, Iraq, Kscien Organization for Scientific Research, Sulaymaniyah, Kurdistan 46001, Iraq, Kscien Organization for Scientific Research, 3082 JJ Rotterdam, The Netherlands, Kscien Organization for Scientific Research, Tampa, FL 33637, USA
Published online on: July 14, 2023 https://doi.org/10.3892/mco.2023.2662
Article Number: 66
Copyright: © Ali et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Renal cell carcinoma (RCC) is a heterogeneous and complex disease with numerous pathophysiologic variants. ~40% of patients succumb due to the progression of the disease, making RCC the most fatal of the common urologic malignancies. Prognostic factors are indicators of the progression of the disease, and the precise determination of these factors is important for evaluating and managing RCC. In the present study, it was aimed to determine and find associations among the histopathological features of RCCs and their impact on survival and metastasis. This is a cross‑sectional study of RCC cases who have undergone partial or radical nephrectomy from March 2008 to October 2021 and have been pathologically reviewed at Shorsh General Teaching Hospital in Sulaimani, Iraq. The data in the pathology studies were supplemented by follow‑up of the patients to obtain information about survival, recurrence and metastasis. In total, 228 cases of RCC were identified, among whom 60.5% were men and 39.5% were women, with a median age of 51 years. The main tumor types were clear cell RCC (71.1%), papillary RCC (13.6%), and chromophobe RCC (11%). Various measures of aggressiveness, including tumor necrosis, sarcomatoid change, microvascular invasion, and parameters of invasiveness (invasion of the renal sinus and other structures), were significantly correlated with each other, and they were also associated with reduced overall survival and an increased risk of metastasis on univariate analysis. However, on multivariate analysis, only tumor size and grade, and microvascular invasion retained statistical significance and were associated with a lower survival rate. In conclusion, pathological parameters have an impact on prognosis in RCC. The most consistent prognostic factors can be tumor size and grade, and microvascular invasion.

View Figures

View References

1	Belldegrun AS: Renal cell carcinoma: Prognostic factors and patient selection. Eur Urol Suppl. 6:477–483. 2007.
2	Bapir R, Hammood ZD, Omar SS, Salih AM, Kakamad FH, Najar KA, et al: Synchronous invasive ductal breast cancer with clear cell renal carcinoma: A rare case report with review of literature. IJS Short Reports. 7(59)2022.
3	Fateh SM, Arkawazi LA, Tahir SH, Rashid RJ, Rahman DH, Aghaways I, Kakamad FH, Salih AM, Bapir R, Fakhralddin SS, et al: Renal cell carcinoma T staging: Diagnostic accuracy of preoperative contrast-enhanced computed tomography. Mol Clin Oncol. 18(11)2023.PubMed/NCBI View Article : Google Scholar
4	Furniss D, Harnden P, Ali N, Royston P, Eisen T, Oliver RT and Hancock BW: National Cancer Research Institute Renal Clinical Studies Group. Prognostic factors for renal cell carcinoma. Cancer Treat Rev. 34:407–426. 2008.PubMed/NCBI View Article : Google Scholar
5	Yurut-Caloglu V, Caloglu M, Kaplan M, Oz-Puyan F, Karagol H, Ibis K, Cosar-Alas R, Kocak Z and Inci O: Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey. Eur J Cancer Care (Engl). 19:656–663. 2010.PubMed/NCBI View Article : Google Scholar
6	Klatte T, Rossi SH and Stewart GD: Prognostic factors and prognostic models for renal cell carcinoma: A literature review. World J Urol. 36:1943–1952. 2018.PubMed/NCBI View Article : Google Scholar
7	Kontak JA and Campbell SC: Prognostic factors in renal cell carcinoma. Urol Clin North Am. 30:467–480. 2003.PubMed/NCBI View Article : Google Scholar
8	Méjean A, Oudard S and Thiounn N: Prognostic factors of renal cell carcinoma. J Urol. 169:821–827. 2003.PubMed/NCBI View Article : Google Scholar
9	Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, Sala N and Gallardo E: Prognostic and predictive factors for renal cell carcinoma. Target Oncol. 13:309–331. 2018.PubMed/NCBI View Article : Google Scholar
10	Volpe A and Patard JJ: Prognostic factors in renal cell carcinoma. World J Urol. 28:319–327. 2010.PubMed/NCBI View Article : Google Scholar
11	Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, et al: AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017.
12	Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 6:655–663. 1982.PubMed/NCBI View Article : Google Scholar
13	Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, et al: The international society of urological pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 37:1490–1504. 2013.PubMed/NCBI View Article : Google Scholar
14	‘SEER Cancer Stat Facts: Kidney and Renal Pelvis Cancer’. National Cancer Institute. Bethesda, MD, 2021. https://seer.cancer.gov/statfacts/html/kidrp.html.
15	Hardi Tariq Hama, Ismaeel Hama Ameen Akhaways and Lusan Abdulhameed Arkawazi: Incidence of Metastatic Renal Cell Carcinoma in Sulaimaniyah Government, Iraq. J Zankoy Sulaimani. 24:102–112. 2022.
16	Weikert S and Ljungberg B: Contemporary epidemiology of renal cell carcinoma: Perspectives of primary prevention. World J Urol. 28:247–252. 2010.PubMed/NCBI View Article : Google Scholar
17	Aron M, Nguyen MM, Stein RJ and Gill IS: Impact of gender in renal cell carcinoma: An analysis of the SEER database. Eur Urol. 54:133–140. 2008.PubMed/NCBI View Article : Google Scholar
18	Kattan M, Reuter V, Motzer R, Katz J and Russo P: A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 166:63–67. 2001.PubMed/NCBI
19	Jiang YL, Peng CX, Wang HZ and Qian LJ: Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: A systematic review and meta-analysis. BMC Urol. 19(48)2019.PubMed/NCBI View Article : Google Scholar
20	Guo S, Yao K, He X, Wu S, Ye Y, Chen J and Wu CL: Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database. Cancer Med. 8:5629–5637. 2019.PubMed/NCBI View Article : Google Scholar
21	Sargin S, Ekmekcioglu O, Arpali E, Altinel M and Voyvoda B: Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma. Urol Int. 82:324–329. 2009.PubMed/NCBI View Article : Google Scholar
22	Zhang C, Li X, Hao H, Yu W, He Z and Zhou L: The correlation between size of renal cell carcinoma and its histopathological characteristics: A single center study of 1867 renal cell carcinoma cases. BJU Int. 110:E481–E485. 2012.PubMed/NCBI View Article : Google Scholar
23	Cheville JC, Lohse CM, Zincke H, Weaver AL and Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 27:612–624. 2003.PubMed/NCBI View Article : Google Scholar
24	Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Srigley JR, Coughlin G, Dunglinson N, Gianduzzo T, Kua B, Malone G, et al: Clear cell renal cell carcinoma: Validation of World Health Organization/International society of urological pathology grading. Histopathology. 71:918–925. 2017.PubMed/NCBI View Article : Google Scholar
25	Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, et al: Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol. 23:2763–2771. 2005.PubMed/NCBI View Article : Google Scholar
26	Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, et al: The international society of urological pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol. 37:1469–1489. 2013.PubMed/NCBI View Article : Google Scholar
27	Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H and Srigley JR: Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol. 35:1134–1139. 2011.PubMed/NCBI View Article : Google Scholar
28	Cornejo KM, Dong F, Zhou AG, Wu CL, Young RH, Braaten K, Sadow PM, Nielsen GP and Oliva E: MPapillary renal cell carcinoma: Correlation of tumor grade and histologic characteristics with clinical outcome. Hum Pathol. 46:1411–1417. 2015.PubMed/NCBI View Article : Google Scholar
29	Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C and Przybycin CG: Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Am J Surg Pathol. 40:1224–1231. 2016.PubMed/NCBI View Article : Google Scholar
30	Katz MD, Serrano MF, Grubb RL, Skolarus TA, Gao F, Humphrey PA and Kibel AS: Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 183:909–914. 2010.PubMed/NCBI View Article : Google Scholar
31	Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC and Kwon ED: Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 104:511–520. 2005.PubMed/NCBI View Article : Google Scholar
32	Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G and Hong SK: Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol. 176:1332–1338. 2006.PubMed/NCBI View Article : Google Scholar
33	Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I and Blute ML: Sarcomatoid renal cell carcinoma: An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 28:435–441. 2004.PubMed/NCBI View Article : Google Scholar
34	de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY and Amin MB: Sarcomatoid differentiation in renal cell carcinoma: A study of 101 cases. Am J Surg Pathol. 25:275–284. 2001.PubMed/NCBI View Article : Google Scholar
35	Gökden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR and Humphrey PA: Renal cell carcinoma with rhabdoid features. Am J Surg Pathol. 24:1329–1338. 2000.PubMed/NCBI View Article : Google Scholar
36	Leroy X, Zini L, Buob D, Ballereau C, Villers A and Aubert S: Renal cell carcinoma with rhabdoid features: An aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med. 131:102–106. 2007.PubMed/NCBI View Article : Google Scholar
37	Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhäuser FD, Shariat SF, Lang H, Rioux-Leclerq N, Remzi M, Zomorodian N, et al: Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol. 187:418–423. 2012.PubMed/NCBI View Article : Google Scholar
38	Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H and Blute ML: Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 174:1218–1221. 2005.PubMed/NCBI View Article : Google Scholar
39	Yoo C, Song C, Hong J, Kim C and Ahn H: Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol. 180:486–491. 2008.PubMed/NCBI View Article : Google Scholar
40	Tongaonkar H, Dandekar N, Dalal A, Kulkarni J and Kamat M: Renal cell carcinoma extending to the renal vein and inferior vena cava: Results of surgical treatment and prognostic factors. J Surg Oncol. 59:94–100. 1995.PubMed/NCBI View Article : Google Scholar
41	Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA and Thompson RH: Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma. BJU Int. 123:270–276. 2019.PubMed/NCBI View Article : Google Scholar
42	Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB and Belldegrun A: Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 163:1090–1295. 2000.PubMed/NCBI View Article : Google Scholar